Kazia Therapeutics【KZIA】銘柄情報

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

通貨

3.40

買値

3.05

売値

3.59

出来高

133,626

3.00 日の範囲 3.64

0.00 52 週間の範囲 0.00

時価総額

11.317M

前日終値

3.33

始値

3.64

時刻

3.35

最終取引時間

財務取引量

US$ 432,025

VWAP

3.2331

平均取引量 (3 か月)

発行済株式数

3,328,508

配当利回り

PER

-0.01

1 株当たり利益 (EPS)

-6.15

歳入

純利益

-20.47M

Kazia Therapeutics Ltd is an oncology-focused biotechnology company, developing innovative anti-cancer drugs. The group is developing GDC-0084, a potential treatment for glioblastoma; Cantrixil, being developed for the treatment of ovarian cancer; and Others. Kazia Therapeutics Ltd is an oncology-focused biotechnology company, developing innovative anti-cancer drugs. The group is developing GDC-0084, a potential treatment for glioblastoma; Cantrixil, being developed for the treatment of ovarian cancer; and Others.

セクター

Pharmaceutical Preparations

業界

Pharmaceutical Preparations

ウェブサイト

www.kaziatherapeutics.com

本社

Sydney, New South Wales, Aus

設立

Kazia Therapeutics Ltd is listed in the Pharmaceutical Preparations sector of the ナスダック市場 with ticker KZIA. The last closing price for Kazia Therapeutics was US$3.33. Over the last year, Kazia Therapeutics shares have traded in a share price range of US$ 0.00 to US$ 0.00.

Kazia Therapeutics currently has 3,328,508 shares in issue. The market capitalisation of Kazia Therapeutics is US$11.08 million. Kazia Therapeutics has a price to earnings ratio (PE ratio) of -0.01.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Kazia Therapeutics to Present Data Highlighting Synergistic Activity Between Paxalisib and Immunotherapy in Immunotherapy-Resistant Triple Negative Breast Cancer Model at the San Antonio Breast Cancer Symposium

Kazia Therapeutics to Present Data Highlighting Synergistic Activity Between Paxalisib and Immunotherapy in Immunotherapy-Resistant Triple Negative Breast Cancer Model at the San Antonio Breast...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	DR
4	0	0	0	0	0	0	0	DR
12	0	0	0	0	0	0	0	DR
26	0	0	0	0	0	0	0	DR
52	0	0	0	0	0	0	0	DR
156	0	0	0	0	0	0	0	DR
260	0	0	0	0	0	0	0	DR

出来高
値上がり率
値下がり率

銘柄コード	株価	出来高
NUKKNukkleus Inc	US$ 11.655 (738.49%)	174.4M
PRTGPortage Biotech Inc	US$ 8.8678 (172.86%)	36.61M
OPTXSyntec Optics Holdings Inc	US$ 3.55 (99.44%)	93.16M
PTPIPetros Pharmaceuticals Inc	US$ 0.4976 (86.37%)	63.49M
LUXHLuxUrban Hotels Inc	US$ 0.849899 (59.67%)	29.52M
VCNXVaccinex Inc	US$ 1.41 (-61.37%)	758.95k
TNYATenaya Therapeutics Inc	US$ 1.395 (-51.56%)	42.45M
ORKTOrangeKloud Technology Inc	US$ 2.14 (-41.85%)	2.29M
RVPHReviva Pharmaceuticals Holdings Inc	US$ 1.395 (-39.35%)	18.16M
DBGIDigital Brands Group Inc	US$ 2.46 (-37.88%)	805.23k
RIMEAlgorhythm Holdings Inc	US$ 0.0877 (8.27%)	1.13B
TNXPTonix Pharmaceuticals Holding Corporation	US$ 0.335 (-36.79%)	1B
GOEVCanoo Inc	US$ 0.118 (7.08%)	382.65M
NVDANVIDIA Corporation	US$ 130.39 (-1.22%)	251.71M
XTIAXTI Aerospace Inc	US$ 0.0442 (8.33%)	221.41M